GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ ® Gene Therapy at the Conclusion of the REFLECT Study
5 months ago
19
-
Homepage
-
Finance
- GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ ® Gene Therapy at the Conclusion of the REFLECT Study